Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 53


Prospective Characterization of the Risk Factors for Transmission and Symptoms of Primary Human Herpesvirus Infections Among Ugandan Infants.

Gantt S, Orem J, Krantz EM, Morrow RA, Selke S, Huang ML, Schiffer JT, Jerome KR, Nakaganda A, Wald A, Casper C, Corey L.

J Infect Dis. 2016 Feb 24. pii: jiw076. [Epub ahead of print]


Precision of the Kalon Herpes Simplex Virus Type 2 IgG ELISA: an international inter-laboratory assessment.

Patel EU, Manucci J, Kahle EM, Lingappa JR, Morrow RA, Piwowar-Manning E, James A, Maluzi KF, Cheeba MM, Gray G, Delany-Moretlwe S, Inambao M, Vwalika B, Quinn TC, Laeyendecker O.

BMC Infect Dis. 2015 Sep 30;15:398. doi: 10.1186/s12879-015-1130-6.


Comparative performance of the Uni-Gold™ HSV-2 Rapid: a point-of-care HSV-2 diagnostic test in unselected sera from a reference laboratory.

Shevlin E, Morrow RA.

J Clin Virol. 2014 Nov;61(3):378-81. doi: 10.1016/j.jcv.2014.08.012. Epub 2014 Aug 27.


Daily oral tenofovir and emtricitabine-tenofovir preexposure prophylaxis reduces herpes simplex virus type 2 acquisition among heterosexual HIV-1-uninfected men and women: a subgroup analysis of a randomized trial.

Celum C, Morrow RA, Donnell D, Hong T, Hendrix CW, Thomas KK, Fife KH, Nakku-Joloba E, Mujugira A, Baeten JM; Partners PrEP Study Team.

Ann Intern Med. 2014 Jul 1;161(1):11-9. doi: 10.7326/M13-2471.


Daily acyclovir to decrease herpes simplex virus type 2 (HSV-2) transmission from HSV-2/HIV-1 coinfected persons: a randomized controlled trial.

Mujugira A, Magaret AS, Celum C, Baeten JM, Lingappa JR, Morrow RA, Fife KH, Delany-Moretlwe S, de Bruyn G, Bukusi EA, Karita E, Kapiga S, Corey L, Wald A; Partners in Prevention HSV/HIV Transmission Study Team.

J Infect Dis. 2013 Nov 1;208(9):1366-74. doi: 10.1093/infdis/jit333. Epub 2013 Jul 30.


HBV lamivudine resistance among hepatitis B and HIV coinfected patients starting lamivudine, stavudine and nevirapine in Kenya.

Kim HN, Scott J, Cent A, Cook L, Morrow RA, Richardson B, Tapia K, Jerome KR, Lule G, John-Stewart G, Chung MH.

J Viral Hepat. 2011 Oct;18(10):e447-52. doi: 10.1111/j.1365-2893.2011.01466.x. Epub 2011 May 13.


Performance of the Focus HerpeSelect-2 enzyme immunoassay for the detection of herpes simplex virus type 2 antibodies in seven African countries.

Mujugira A, Morrow RA, Celum C, Lingappa J, Delany-Moretlwe S, Fife KH, Heffron R, De Bruyn G, Homawoo B, Karita E, Mugo N, Vwalika B, Baeten JM; Partners in Prevention HSV/HIV Transmission Study Team.

Sex Transm Infect. 2011 Apr;87(3):238-41. doi: 10.1136/sti.2010.047415. Epub 2011 Feb 9.


Sensitivity and specificity of herpes simplex virus-2 serological assays among HIV-infected and uninfected urban Ugandans.

Lingappa J, Nakku-Joloba E, Magaret A, Friedrich D, Dragavon J, Kambugu F, Joloba M, Whalen C, Coombs R, Celum C, Morrow RA.

Int J STD AIDS. 2010 Sep;21(9):611-6. doi: 10.1258/ijsa.2009.008477.


Performance of commercial herpes simplex virus type-2 antibody tests using serum samples from Sub-Saharan Africa: a systematic review and meta-analysis.

Biraro S, Mayaud P, Morrow RA, Grosskurth H, Weiss HA.

Sex Transm Dis. 2011 Feb;38(2):140-7. doi: 10.1097/OLQ.0b013e3181f0bafb. Review.


Performance of HSV-2 type specific serological tests in men in Kenya.

Ng'ayo MO, Friedrich D, Holmes KK, Bukusi E, Morrow RA.

J Virol Methods. 2010 Feb;163(2):276-81. doi: 10.1016/j.jviromet.2009.10.009. Epub 2009 Oct 23.


Microbial antagonists of Escherichia coli O157:H7 on fresh-cut lettuce and spinach.

Johnston MA, Harrison MA, Morrow RA.

J Food Prot. 2009 Jul;72(7):1569-75.


Use of the systems approach to determine the fate of Escherichia coli O157:H7 on fresh lettuce and spinach.

Doering HJ, Harrison MA, Morrow RA, Hurst WC, Kerr WL.

J Food Prot. 2009 Jul;72(7):1560-8.


Herpes simplex virus type-2 seropositivity among ever married women in South and north Vietnam: a population-based study.

Le HV, Schoenbach VJ, Herrero R, Hoang Pham AT, Nguyen HT, Nguyen TT, Muñoz N, Franceschi S, Vaccarella S, Parkin MD, Snijders PJ, Morrow RA, Smith JS.

Sex Transm Dis. 2009 Oct;36(10):616-20. doi: 10.1097/OLQ.0b013e3181a8cde4.


Herpes simplex virus type 2 antibody detection performance in Kisumu, Kenya, using the Herpeselect ELISA, Kalon ELISA, Western blot and inhibition testing.

Smith JS, Bailey RC, Westreich DJ, Maclean I, Agot K, Ndinya-Achola JO, Hogrefe W, Morrow RA, Moses S.

Sex Transm Infect. 2009 Apr;85(2):92-6. doi: 10.1136/sti.2008.031815. Epub 2008 Oct 27.


Comparison of three commercial immunoassays for detection of herpes simplex virus type 2 antibodies in commercial sex workers in Yunnan Province, China.

Ngo TD, Laeyendecker O, Morrow RA, Lai S, Quinn TC.

Clin Vaccine Immunol. 2008 Aug;15(8):1301-3. doi: 10.1128/CVI.00006-08. Epub 2008 May 28.


Improved performance of enzyme-linked immunosorbent assays and the effect of human immunodeficiency virus coinfection on the serologic detection of herpes simplex virus type 2 in Rakai, Uganda.

Gamiel JL, Tobian AA, Laeyendecker OB, Reynolds SJ, Morrow RA, Serwadda D, Gray RH, Quinn TC.

Clin Vaccine Immunol. 2008 May;15(5):888-90. doi: 10.1128/CVI.00453-07. Epub 2008 Mar 5.


Type-specific seroprevalence of herpes simplex virus type 2 and associated risk factors in middle-aged women from 6 countries: the IARC multicentric study.

Patnaik P, Herrero R, Morrow RA, Munoz N, Bosch FX, Bayo S, El Gueddari B, Caceres E, Chichareon SB, Castellsague X, Meijer CJ, Snijders PJ, Smith JS.

Sex Transm Dis. 2007 Dec;34(12):1019-24.


Use of commercial enzyme immunoassays to detect antibodies to the herpes simplex virus type 2 glycoprotein G in a low-risk population in Hanoi, Vietnam.

Ngo TD, Laeyendecker O, La H, Hogrefe W, Morrow RA, Quinn TC.

Clin Vaccine Immunol. 2008 Feb;15(2):382-4. Epub 2007 Dec 12.


Seroprevalence of herpes simplex virus type 1 in children in the United States.

Xu F, Lee FK, Morrow RA, Sternberg MR, Luther KE, Dubin G, Markowitz LE.

J Pediatr. 2007 Oct;151(4):374-7. Epub 2007 Aug 10.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk